BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alix-Panabières C, Pantel K. Liquid Biopsy: From Discovery to Clinical Application. Cancer Discov 2021;11:858-73. [PMID: 33811121 DOI: 10.1158/2159-8290.CD-20-1311] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Belousov PV. The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges. Biomedicines 2022;10:468. [DOI: 10.3390/biomedicines10020468] [Reference Citation Analysis]
2 Dirix L, Buys A, Oeyen S, Peeters D, Liègeois V, Prové A, Rondas D, Vervoort L, Mariën V, Laere SV, Vermeulen P. Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer. Breast Cancer Res Treat 2022. [PMID: 35397078 DOI: 10.1007/s10549-022-06585-5] [Reference Citation Analysis]
3 Hedtke M, Pessoa Rejas R, Froelich MF, Ast V, Duda A, Mirbach L, Costina V, Martens UM, Hofheinz RD, Neumaier M, Haselmann V. Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care. Mol Oncol 2021. [PMID: 34873826 DOI: 10.1002/1878-0261.13156] [Reference Citation Analysis]
4 Wang T, Denman D, Bacot SM, Feldman GM. Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy. Biomedicines 2022;10:1181. [DOI: 10.3390/biomedicines10051181] [Reference Citation Analysis]
5 Timmerman DM, Gillis AJM, Mego M, Looijenga LHJ. Comparative Analyses of Liquid-Biopsy MicroRNA371a-3p Isolation Protocols for Serum and Plasma. Cancers (Basel) 2021;13:4260. [PMID: 34503070 DOI: 10.3390/cancers13174260] [Reference Citation Analysis]
6 Paschold L, Binder M. Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer. Current Oncology 2022;29:1430-41. [DOI: 10.3390/curroncol29030120] [Reference Citation Analysis]
7 Zhou K, Liu Y, Yuan Q, Lai D, Guo S, Wang Z, Su L, Zhang H, Wang X, Guo W, Ji X, Gu X, Huang Q, Guo X, Xing J. Next-Generation Sequencing-Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients. Clin Chem 2022:hvab268. [PMID: 34993545 DOI: 10.1093/clinchem/hvab268] [Reference Citation Analysis]
8 Petrou L, Ladame S. On-chip miRNA extraction platforms: recent technological advances and implications for next generation point-of-care nucleic acid tests. Lab Chip 2022. [PMID: 35048934 DOI: 10.1039/d1lc00868d] [Reference Citation Analysis]
9 Peng Y, Mei W, Ma K, Zeng C. Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives. Front Oncol 2021;11:763790. [PMID: 34868984 DOI: 10.3389/fonc.2021.763790] [Reference Citation Analysis]
10 Moldogazieva NT, Zavadskiy SP, Terentiev AA. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine. Cancer Genomics Proteomics 2021;18:369-83. [PMID: 33994362 DOI: 10.21873/cgp.20266] [Reference Citation Analysis]
11 Geidel G, Heidrich I, Kött J, Schneider SW, Pantel K, Gebhardt C. Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma. NPJ Precis Oncol 2022;6:17. [PMID: 35322182 DOI: 10.1038/s41698-022-00261-z] [Reference Citation Analysis]
12 Eslami-S Z, Cortés-Hernández LE, Thomas F, Pantel K, Alix-Panabières C. Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade. Br J Cancer 2022. [PMID: 35484215 DOI: 10.1038/s41416-022-01819-1] [Reference Citation Analysis]
13 Lang F, Contreras-Gerenas MF, Gelléri M, Neumann J, Kröger O, Sadlo F, Berniak K, Marx A, Cremer C, Wagenknecht HA, Allgayer H. Tackling Tumour Cell Heterogeneity at the Super-Resolution Level in Human Colorectal Cancer Tissue. Cancers (Basel) 2021;13:3692. [PMID: 34359592 DOI: 10.3390/cancers13153692] [Reference Citation Analysis]
14 Barbirou M, Miller A, Manjunath Y, Ramirez AB, Ericson NG, Staveley-o’carroll KF, Mitchem JB, Warren WC, Chaudhuri AA, Huang Y, Li G, Tonellato PJ, Kaifi JT. Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients. CIMB 2022;44:750-63. [DOI: 10.3390/cimb44020052] [Reference Citation Analysis]
15 Xu Y, Jiang Y, Yu M, Lou J, Song M, Xu H, Cui Y, Zeng X, Wang Q, Ma H, Wang Z, Zhu S, Li G, Zhao A. Meta-Analysis of the Diagnostic Value of Cell-free DNA for Renal Cancer. Front Mol Biosci 2021;8:683844. [PMID: 34458320 DOI: 10.3389/fmolb.2021.683844] [Reference Citation Analysis]
16 Meichner K, Mccleary-wheeler AL, Mochizuki H, Stokol T. Editorial: Comparative Oncology–Advances in Veterinary Molecular Oncology. Front Vet Sci 2022;8:812856. [DOI: 10.3389/fvets.2021.812856] [Reference Citation Analysis]
17 Alix-Panabières C, Pantel K. Liquid biopsy: from discovery to clinical implementation. Mol Oncol 2021;15:1617-21. [PMID: 34075709 DOI: 10.1002/1878-0261.12997] [Reference Citation Analysis]
18 Ntzifa A, Londra D, Rampias T, Kotsakis A, Georgoulias V, Lianidou E. DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment. Cancers (Basel) 2021;13:5974. [PMID: 34885084 DOI: 10.3390/cancers13235974] [Reference Citation Analysis]
19 Obermayr E, Braicu EI, Polterauer S, Loverix L, Concin N, Woelber L, Mahner S, Sehouli J, Van Gorp T, Vergote I, Zeillinger R, Aust S. Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD Consortium. Cancers (Basel) 2021;13:5865. [PMID: 34884980 DOI: 10.3390/cancers13235865] [Reference Citation Analysis]
20 Liu W, Luo Y, Dai J, Yang L, Huang L, Wang R, Chen W, Huang Y, Sun S, Cao J, Wu J, Han M, Fan J, He M, Qian K, Fan X, Jia R. Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting. Small Methods 2022;6:e2101220. [PMID: 35041286 DOI: 10.1002/smtd.202101220] [Reference Citation Analysis]
21 Haselmann V, Hedtke M, Neumaier M. Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care. Diagnostics 2022;12:748. [DOI: 10.3390/diagnostics12030748] [Reference Citation Analysis]
22 Silva VSE, Abdallah EA, Flores BCT, Braun AC, Costa DJF, Ruano APC, Gasparini VA, Silva MLG, Mendes GG, Claro LCL, Calsavara VF, Aguiar Junior S, de Mello CAL, Chinen LTD. Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer. Cells 2021;10:1539. [PMID: 34207124 DOI: 10.3390/cells10061539] [Reference Citation Analysis]
23 Neinavaie F, Ibrahim-hashim A, Kramer AM, Brown JS, Richards CL. The Genomic Processes of Biological Invasions: From Invasive Species to Cancer Metastases and Back Again. Front Ecol Evol 2021;9:681100. [DOI: 10.3389/fevo.2021.681100] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Alese OB, Cook N, Ortega-Franco A, Ulanja MB, Tan L, Tie J. Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers. Am Soc Clin Oncol Educ Book 2022;42:1-20. [PMID: 35471832 DOI: 10.1200/EDBK_349143] [Reference Citation Analysis]
25 Merkens L, Sailer V, Lessel D, Janzen E, Greimeier S, Kirfel J, Perner S, Pantel K, Werner S, von Amsberg G. Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation. J Exp Clin Cancer Res 2022;41:46. [PMID: 35109899 DOI: 10.1186/s13046-022-02255-y] [Reference Citation Analysis]
26 Balcik-Ercin P, Cayrefourcq L, Soundararajan R, Mani SA, Alix-Panabières C. Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer. Cancers (Basel) 2021;13:5408. [PMID: 34771571 DOI: 10.3390/cancers13215408] [Reference Citation Analysis]
27 Abdalla TSA, Meiners J, Riethdorf S, König A, Melling N, Gorges T, Karstens KF, Izbicki JR, Pantel K, Reeh M. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer. PLoS One 2021;16:e0252897. [PMID: 34111181 DOI: 10.1371/journal.pone.0252897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Knipper S, Riethdorf S, Werner S, Tilki D, Graefen M, Pantel K, Maurer T. Possible Role of Circulating Tumour Cells for Prediction of Salvage Lymph Node Dissection Outcome in Patients with Early Prostate Cancer Recurrence. Eur Urol Open Sci 2021;34:55-8. [PMID: 34786563 DOI: 10.1016/j.euros.2021.09.017] [Reference Citation Analysis]
29 Gwark S, Ahn H, Yeom J, Yu J, Oh Y, Jeong JH, Ahn J, Jung KH, Kim S, Lee HJ, Gong G, Lee SB, Chung IY, Kim HJ, Ko BS, Lee JW, Son BH, Ahn SH, Kim K, Kim J. Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers 2021;13:6267. [DOI: 10.3390/cancers13246267] [Reference Citation Analysis]
30 Leong SP, Naxerova K, Keller L, Pantel K, Witte M. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clin Exp Metastasis 2021. [PMID: 34767139 DOI: 10.1007/s10585-021-10120-z] [Reference Citation Analysis]
31 Conteduca D, Quinn SD, Krauss TF. Dielectric metasurface for high-precision detection of large unilamellar vesicles. J Opt 2021;23:114002. [DOI: 10.1088/2040-8986/ac2dd7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Peng Z, Hu Q, Fang S, Zhang X, Hong X, Tao L, Pan J, Jiang M, Bai H, Wu Y, Zhao X, Zhou C, Chen J, Han Y, Gong Z. Circulating circTOLLIP serves as a diagnostic biomarker for liquid biopsy in non-small cell lung cancer. Clin Chim Acta 2021;523:415-22. [PMID: 34728180 DOI: 10.1016/j.cca.2021.10.038] [Reference Citation Analysis]
33 Moonmuang S, Chaiyawat P, Jantrapirom S, Pruksakorn D, Lo Piccolo L. Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma. Cancers 2021;13:4214. [DOI: 10.3390/cancers13164214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Heidrich I, Abdalla TSA, Reeh M, Pantel K. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer. Cancers (Basel) 2021;13:4500. [PMID: 34572727 DOI: 10.3390/cancers13184500] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Aldea M, Cerbone L, Bayle A, Parisi C, Sarkozy C, Vasseur D, Verlingue L, Blanc-Durand F, Mosele F, Sakkal M, Ponce S, Lavaud P, Loriot Y, Hollebecque A, Massard C, Soria JC, Lacroix L, Rouleau E, Italiano A. Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients. Ann Oncol 2021;32:1642-5. [PMID: 34509616 DOI: 10.1016/j.annonc.2021.09.002] [Reference Citation Analysis]
36 Engavale M, Mccord J, Mapp B, Nzimulinda N, Bengtson E, Sutton RB, Keyel PA. Dnase1 Family in Autoimmunity. Encyclopedia 2021;1:527-41. [DOI: 10.3390/encyclopedia1030044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Cortés-Hernández LE, Eslami-S Z, Costa-Silva B, Alix-Panabières C. Current Applications and Discoveries Related to the Membrane Components of Circulating Tumor Cells and Extracellular Vesicles. Cells 2021;10:2221. [PMID: 34571870 DOI: 10.3390/cells10092221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Sánchez-Herrero E, Serna-Blasco R, Ivanchuk V, García-Campelo R, Dómine Gómez M, Sánchez JM, Massutí B, Reguart N, Camps C, Sanz-Moreno S, Calabuig-Fariñas S, Jantus-Lewintre E, Arnal M, Fernández-Orth D, Calvo V, González-Rumayor V, Provencio M, Romero A. NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Mol Oncol 2021;15:2363-76. [PMID: 34058070 DOI: 10.1002/1878-0261.13033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Kalfa N. The Changing Face of Pediatric Urology: Blurring the Lines. Journal of Pediatric Urology 2022. [DOI: 10.1016/j.jpurol.2022.04.010] [Reference Citation Analysis]
40 Dujon AM, Capp JP, Brown JS, Pujol P, Gatenby RA, Ujvari B, Alix-Panabières C, Thomas F. Is There One Key Step in the Metastatic Cascade? Cancers (Basel) 2021;13:3693. [PMID: 34359593 DOI: 10.3390/cancers13153693] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Marimpietri D, Airoldi I, Faini AC, Malavasi F, Morandi F. The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma. Int J Mol Sci 2021;22:3964. [PMID: 33921337 DOI: 10.3390/ijms22083964] [Reference Citation Analysis]
42 Romano C, Martorana F, Pennisi MS, Stella S, Massimino M, Tirrò E, Vitale SR, Di Gregorio S, Puma A, Tomarchio C, Manzella L. Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer. Int J Mol Sci 2021;22:7707. [PMID: 34299334 DOI: 10.3390/ijms22147707] [Reference Citation Analysis]
43 Wang L, Wu J, Ye N, Li F, Zhan H, Chen S, Xu J. Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer. Front Oncol 2021;11:739111. [PMID: 34589435 DOI: 10.3389/fonc.2021.739111] [Reference Citation Analysis]
44 Pantel K. Liquid Biopsy: Blood-Based Analyses of ctDNA and CTCs. Clin Chem 2021;67:1437-9. [PMID: 34549290 DOI: 10.1093/clinchem/hvab168] [Reference Citation Analysis]
45 Terasawa H, Kinugasa H, Nouso K, Yamamoto S, Hirai M, Tanaka T, Takaki A, Okada H. Circulating tumor DNA dynamics analysis in a xenograft mouse model with esophageal squamous cell carcinoma. World J Gastroenterol 2021; 27(41): 7134-7143 [PMID: 34887633 DOI: 10.3748/wjg.v27.i41.7134] [Reference Citation Analysis]
46 Lengel HB, Connolly JG, Jones GD, Caso R, Zhou J, Sanchez-Vega F, Mastrogiacomo B, Isbell JM, Li BT, Liu Y, Rekhtman N, Jones DR. The Emerging Importance of Tumor Genomics in Operable Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:3656. [PMID: 34359558 DOI: 10.3390/cancers13153656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Froelich MF, Capoluongo E, Kovacs Z, Patton SJ, Lianidou ES, Haselmann V. The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group "CNAPS/CTC for early detection of cancer". Clin Chem Lab Med 2022. [PMID: 35218176 DOI: 10.1515/cclm-2022-0129] [Reference Citation Analysis]
48 Markou Α, Londra D, Tserpeli V, Kollias Ι, Tsaroucha E, Vamvakaris I, Potaris K, Pateras I, Kotsakis Α, Georgoulias V, Lianidou Ε. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection. Clin Epigenetics 2022;14:61. [PMID: 35538556 DOI: 10.1186/s13148-022-01283-x] [Reference Citation Analysis]
49 Pallante P, Malapelle U, Nacchio M, Sgariglia R, Galati D, Capitelli L, Zanotta S, Galgani M, Piemonte E, Sanduzzi Zamparelli A, Rea G, Bocchino M. Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis. Diagnostics (Basel) 2021;11:1202. [PMID: 34359285 DOI: 10.3390/diagnostics11071202] [Reference Citation Analysis]
50 Aleotti V, Catoni C, Poggiana C, Rosato A, Facchinetti A, Scaini MC. Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy. Cancers (Basel) 2021;13:6217. [PMID: 34944843 DOI: 10.3390/cancers13246217] [Reference Citation Analysis]
51 Castaño N, Kim S, Martin AM, Galli SJ, Nadeau KC, Tang SKY. Exponential magnetophoretic gradient for the direct isolation of basophils from whole blood in a microfluidic system. Lab Chip 2022. [PMID: 35438713 DOI: 10.1039/d2lc00154c] [Reference Citation Analysis]
52 Gambardella V, Candia L, Tapia M, Cejalvo JM, Cervantes A. In the literature: June 2021. ESMO Open 2021;6:100186. [PMID: 34098228 DOI: 10.1016/j.esmoop.2021.100186] [Reference Citation Analysis]
53 Pauken CM, Kenney SR, Brayer KJ, Guo Y, Brown-Glaberman UA, Marchetti D. Heterogeneity of Circulating Tumor Cell Neoplastic Subpopulations Outlined by Single-Cell Transcriptomics. Cancers (Basel) 2021;13:4885. [PMID: 34638368 DOI: 10.3390/cancers13194885] [Reference Citation Analysis]
54 Ramirez JG, Smit DJ, Viol F, Schrader J, Ghadban T, Pantel K, Izbicki JR, Reeh M. High Serum Levels of Wnt Signaling Antagonist Dickkopf-Related Protein 1 Are Associated with Impaired Overall Survival and Recurrence in Esophageal Cancer Patients. Cancers (Basel) 2021;13:4980. [PMID: 34638464 DOI: 10.3390/cancers13194980] [Reference Citation Analysis]
55 Ding Z, Wang N, Ji N, Chen ZS. Proteomics technologies for cancer liquid biopsies. Mol Cancer 2022;21:53. [PMID: 35168611 DOI: 10.1186/s12943-022-01526-8] [Reference Citation Analysis]
56 Kamińska P, Buszka K, Zabel M, Nowicki M, Alix-Panabières C, Budna-Tukan J. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring. Int J Mol Sci 2021;22:9714. [PMID: 34575876 DOI: 10.3390/ijms22189714] [Reference Citation Analysis]
57 Wang SQ, Chai CX, Wang BR, Zhu F, Shang D, Li M. Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma. World J Gastrointest Oncol 2022; 14(1): 362-365 [DOI: 10.4251/wjgo.v14.i1.362] [Reference Citation Analysis]
58 Dermody SM, Bhambhani C, Swiecicki PL, Brenner JC, Tewari M. Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of Cancer. Front Genet 2022;13:879108. [DOI: 10.3389/fgene.2022.879108] [Reference Citation Analysis]
59 Kepesidis KV, Bozic-Iven M, Huber M, Abdel-Aziz N, Kullab S, Abdelwarith A, Al Diab A, Al Ghamdi M, Hilal MA, Bahadoor MRK, Sharma A, Dabouz F, Arafah M, Azzeer AM, Krausz F, Alsaleh K, Zigman M, Nabholtz JM. Breast-cancer detection using blood-based infrared molecular fingerprints. BMC Cancer 2021;21:1287. [PMID: 34856945 DOI: 10.1186/s12885-021-09017-7] [Reference Citation Analysis]